PBE Holdings Information

PBE is an equity ETF with a total of 33 individual holdings. The top holdings are Illumina stock at 5.51%, United Therapeutics at 5.04%, Regeneron Pharmaceuticals at 4.93%, Biogen at 4.85%, and Amgen at 4.71%.

Total Holdings

Top 10 Percentage

46.37%

Asset Class

Equity

ETF Category

Health

Assets

260.30M

PE Ratio

22.30

Sector Allocation

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	ILMN	Illumina, Inc.	5.51%	101,643
2	UTHR	United Therapeutics Corporation	5.04%	26,829
3	REGN	Regeneron Pharmaceuticals, Inc.	4.93%	16,813
4	BIIB	Biogen Inc.	4.85%	72,406
5	AMGN	Amgen Inc.	4.71%	38,297
6	INCY	Incyte Corporation	4.71%	120,509
7	GILD	Gilead Sciences, Inc.	4.64%	102,202
8	ALNY	Alnylam Pharmaceuticals, Inc.	4.50%	29,483
9	FOLD	Amicus Therapeutics, Inc.	3.86%	706,109
10	DVAX	Dynavax Technologies Corporation	3.61%	610,438
11	MNKD	MannKind Corporation	2.94%	1,361,290
12	ACAD	ACADIA Pharmaceuticals Inc.	2.93%	292,193
13	BCRX	BioCryst Pharmaceuticals, Inc.	2.91%	1,022,462
14	BMRN	BioMarin Pharmaceutical Inc.	2.84%	125,827
15	RGEN	Repligen Corporation	2.72%	41,751
16	EXEL	Exelixis, Inc.	2.69%	165,287
17	COLL	Collegium Pharmaceutical, Inc.	2.69%	153,229
18	MDGL	Madrigal Pharmaceuticals, Inc.	2.68%	11,878
19	IONS	Ionis Pharmaceuticals, Inc.	2.68%	88,937
20	RPRX	Royalty Pharma plc	2.67%	175,683
21	TECH	Bio-Techne Corporation	2.66%	109,992
22	QGEN	Qiagen N.V.	2.64%	147,891
23	CPRX	Catalyst Pharmaceuticals, Inc.	2.60%	297,040
24	NBIX	Neurocrine Biosciences, Inc.	2.58%	49,439
25	HALO	Halozyme Therapeutics, Inc.	2.58%	94,370

Showing 25 of 33 holdings

Subscribe to see the full list

Activate Now

As of Jan 5, 2026